Matthew R. Patterson, Chief Operating Officer at AMICUS THERAPEUTICS INC (FOLD), sold 5,500 shares at $10.32 ($58K) on 2008-04-14, disclosed to the SEC on 2008-04-16.
Scheduled sale ($58k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.00 | 100 | $1K | 1.7% |
| 2 | $10.12 | 100 | $1K | 1.8% |
| 3 | $10.14 | 400 | $4K | 7.0% |
| 4 | $10.19 | 100 | $1K | 1.8% |
| 5 | $10.22 | 304 | $3K | 5.4% |
| 6 | $10.24 | 796 |
| $8K |
| 14.1% |
| 7 | $10.32 | 100 | $1K | 1.8% |
| 8 | $10.36 | 4 | $41 | 0.1% |
| 9 | $10.37 | 96 | $996 | 1.7% |
| 10 | $10.48 | 100 | $1K | 1.8% |
| 11 | $10.56 | 300 | $3K | 5.5% |
| 12 | $10.57 | 200 | $2K | 3.7% |
| 13 | $10.61 | 1,000 | $11K | 18.4% |
| 14 | $10.62 | 91 | $966 | 1.7% |
| 15 | $10.64 | 200 | $2K | 3.7% |
| 16 | $10.65 | 600 | $6K | 11.1% |
| 17 | $10.66 | 200 | $2K | 3.7% |
| 18 | $10.67 | 9 | $96 | 0.2% |
| 19 | $10.68 | 200 | $2K | 3.7% |
| 20 | $10.69 | 100 | $1K | 1.9% |
| 21 | $10.70 | 200 | $2K | 3.7% |
| 22 | $10.71 | 100 | $1K | 1.9% |
| 23 | $10.73 | 200 | $2K | 3.7% |
| Total | $10.48 avg | 5,500 | $58K | 100% |
| Filing → |
| BOLD | SELL | 2019-02-27 | $630K | — | Filing → |
| BOLD | SELL | 2018-10-02 | $1.6M | — | Filing → |
| BOLD | SELL | 2018-09-20 | $518K | — | Filing → |